BNP Paribas Financial Markets’s Greenwich LifeSciences GLSI Stock Holding History

BNP Paribas Financial Markets’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.5K	Sell	1,597 -135	-8%	-$3.29K	﹤0.01%	5022
2026 Q1	$41.6K	Sell	1,732 -108	-6%	-$2.82K	﹤0.01%	4791
2025 Q4	$38.7K	Buy	1,840 +702	+62%	+$7.39K	﹤0.01%	4794
2025 Q3	$11.3K	Buy	1,138 +498	+78%	+$5.62K	﹤0.01%	4994
2025 Q2	$5.8K	Buy	640 +216	+51%	+$2.06K	﹤0.01%	4941
2025 Q1	$4.04K	Sell	424 -652	-61%	-$7.91K	﹤0.01%	4888
2024 Q4	$12.1K	Buy	+1,076	New	+$14.4K	﹤0.01%	4820

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets's GLSI Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Greenwich LifeSciences (GLSI) stake by 7.8% in Q2 2026, selling an estimated $3.29K and leaving 1,597 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5022.

BNP Paribas Financial Markets first reported a position in GLSI in Q4 2024 and has held it in 7 quarters since. The position peaked at $41.6K in Q1 2026. 56 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

BNP Paribas Financial Markets held 1,597 shares of Greenwich LifeSciences worth $37.5K as of Q2 2026.
BNP Paribas Financial Markets sold 135 Greenwich LifeSciences shares in Q2 2026, an estimated $3.29K.
Greenwich LifeSciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5022 holding.
BNP Paribas Financial Markets first reported a position in Greenwich LifeSciences in Q4 2024 and has held it in 7 quarters since.
BNP Paribas Financial Markets's Greenwich LifeSciences position peaked at $41.6K in Q1 2026.
56 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.